Brian A. Markison

Brian A. Markison is a declared insider at 2 companies (board member); the most frequent names are Lantheus Holdings, Inc. and RVL Pharmaceuticals plc. The record holds 26 filings, for trades running from 16 April 2019 to 5 March 2025.

In open-market terms, that means 1 purchase worth €1.3M on one side and 12 sales worth €2.2M on the other. Taken together, the sales exceed the purchases by €941k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 10 share grants and 3 option exercises.

On 7 March 2025 came the latest disclosure, a share grant in Lantheus Holdings, Inc. The most recent open-market purchase was published on 9 August 2022, 1,537 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.